Johnny Samijn

Johnny Samijn is a Researcher in the Department of Neurology at Erasmus Medical Center, actively contributing to neurological research with a focus on Guillain-Barré Syndrome (GBS) and cerebrospinal fluid (CSF) analysis. His work addresses critical aspects of neurological disorders, particularly those involving respiratory complications.

Dr. Samijn's primary research interests include:

• Neurology
• Cerebrospinal Fluid Research
• Guillain-Barré Syndrome
• Respiratory Failure
• Disease Course Analysis
• Artificial Respiration

His recent publications demonstrate a consistent trajectory in understanding neurological disorders with respiratory implications. The 2023 Neurology paper established relationships between CSF findings and clinical characteristics in GBS patients, while the 2022 Annals of Neurology article validated an important clinical scoring system for predicting respiratory failure in GBS. His most recent 2024 work addresses challenges in MOG antibody testing for multiple sclerosis, indicating expanding research interests into related neuroimmunological conditions.

Dr. Samijn has achieved significant scholarly impact, with his 2012 paper accumulating 74 Scopus citations and his 2022 paper receiving 29 citations. His research has been disseminated through high-impact journals including Neurology, Annals of Neurology, and Multiple Sclerosis and Related Disorders, and has garnered attention across social media platforms and news outlets.

He actively collaborates through the IGOS Consortium and has co-authored papers with international researchers across multiple continents, contributing to the global understanding and management of Guillain-Barré Syndrome.